OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting cancer using KAT inhibitors to mimic lethal knockouts
James A. L. Brown, Emer Bourke, Leif A. Eriksson, et al.
Biochemical Society Transactions (2016) Vol. 44, Iss. 4, pp. 979-986
Open Access | Times Cited: 60

Showing 26-50 of 60 citing articles:

Evaluating the Cellular Roles of the Lysine Acetyltransferase Tip60 in Cancer: A Multi-Action Molecular Target for Precision Oncology
Nazanin Zohourian, Erin Coll, Muiread Dever, et al.
Cancers (2024) Vol. 16, Iss. 15, pp. 2677-2677
Open Access | Times Cited: 2

Epi-drugs as triple-negative breast cancer treatment
Mouhamed Idrissou, Anna Sánchez, Frédérique Penault‐Llorca, et al.
Epigenomics (2020) Vol. 12, Iss. 8, pp. 725-742
Closed Access | Times Cited: 17

Pharmacological inhibition of the acetyltransferase Tip60 mitigates myocardial infarction injury
Xinrui Wang, Tina C. Wan, Katherine Kulik, et al.
Disease Models & Mechanisms (2022) Vol. 16, Iss. 5
Open Access | Times Cited: 10

KAT3B-p300 and H3AcK18/H3AcK14 levels are prognostic markers for kidney ccRCC tumor aggressiveness and target of KAT inhibitor CPTH2
Elisa Cocco, Manuela Leo, Claudia Canzonetta, et al.
Clinical Epigenetics (2018) Vol. 10, Iss. 1
Open Access | Times Cited: 17

Role of histone acetyltransferase inhibitors in cancer therapy
Muthu K. Shanmugam, Arun Dharmarajan, Sudha Warrier, et al.
Advances in protein chemistry and structural biology (2020), pp. 149-191
Closed Access | Times Cited: 15

TIP60 governs the auto‑ubiquitination of UHRF1 through USP7 dissociation from the UHRF1/USP7 complex
Tanveer Ahmad, Waseem Ashraf, Abdulkhaleg Ibrahim, et al.
International Journal of Oncology (2021) Vol. 59, Iss. 5
Open Access | Times Cited: 14

SP1 and RARα regulate AGAP2 expression in cancer
Yegor Doush, Arif A. Surani, Amaia Navarro‐Corcuera, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 13

Tip60‑siRNA regulates ABCE1 acetylation to suppress lung cancer growth via activation of the apoptotic signaling pathway
Zongying Liang, Qian Yu, Hongtao Ji, et al.
Experimental and Therapeutic Medicine (2019)
Open Access | Times Cited: 13

Histone Deacetylases (HDACs) Roles in Inflammation-mediated Diseases; Current Knowledge
Saade Abdalkareem Jasim, Farag M. A. Altalbawy, Mohammad Abohassan, et al.
Cell Biochemistry and Biophysics (2024)
Closed Access | Times Cited: 1

TIP60 up-regulates ΔNp63α to promote cellular proliferation
Andrew J. Stacy, Jin Zhang, Michael P. Craig, et al.
Journal of Biological Chemistry (2019) Vol. 294, Iss. 45, pp. 17007-17016
Open Access | Times Cited: 11

Patent Spotlight: small-molecule Lysine Acetyltransferase Inhibitors (KATi)
James A. L. Brown
Pharmaceutical Patent Analyst (2020) Vol. 9, Iss. 1, pp. 17-28
Closed Access | Times Cited: 9

Epigenetic control of microsomal prostaglandin E synthase-1 by HDAC-mediated recruitment of p300
Christian Fork, Andrea E Vasconez, Patrick Janetzko, et al.
Journal of Lipid Research (2016) Vol. 58, Iss. 2, pp. 386-392
Open Access | Times Cited: 8

Prediction of Distant Metastases in Patients with Kidney Cancer Based on Gene Expression and Methylation Analysis
Н. В. Апанович, Alexey S. Matveev, Н. В. Иванова, et al.
Diagnostics (2023) Vol. 13, Iss. 13, pp. 2289-2289
Open Access | Times Cited: 3

Benefits and pitfalls: Epigenetic modulators in prostate cancer intervention
Neha Upadhyay, Kalpana Tilekar, Jessica D. Hess, et al.
Current Research in Chemical Biology (2021) Vol. 1, pp. 100006-100006
Open Access | Times Cited: 7

A Review on Important Histone Acetyltransferase (HAT) Enzymes as Targets for Cancer Therapy
Mohammad Ghanbari, Reza Safaralizadeh, Kiyanoush Mohammadi
Current Cancer Therapy Reviews (2018) Vol. 15, Iss. 2, pp. 120-130
Closed Access | Times Cited: 5

The Acetyltransferase KAT5 Inhibitor NU 9056 Promotes Apoptosis and Inhibits JAK2/STAT3 Pathway in Extranodal NK/T Cell Lymphoma
Wei Sang, Kailin Xu, Linyan Xu, et al.
Anti-Cancer Agents in Medicinal Chemistry (2021) Vol. 22, Iss. 8, pp. 1530-1540
Closed Access | Times Cited: 5

KAT5 histone acetyltransferase mutations in cancer cells.
Kimberly L Hardison, Tila M Hawk, Renee A. Bouley, et al.
PubMed (2022) Vol. 2022
Closed Access | Times Cited: 3

Acylases
James A. L. Brown, Wayne W. Hancock
(2024), pp. 1-57
Closed Access

Digging Deeper into Breast Cancer Epigenetics: Insights from Chemical Inhibition of Histone Acetyltransferase TIP60 In Vitro
Mouhamed Idrissou, Isabelle Lebert, Tiphanie Boisnier, et al.
OMICS A Journal of Integrative Biology (2020) Vol. 24, Iss. 10, pp. 581-591
Closed Access | Times Cited: 3

Epigenetic changes driving therapy resistance in prostate cancer
George Doumat, Elia Abou Chawareb, Towfik N. Sebai, et al.
Elsevier eBooks (2023), pp. 85-106
Closed Access | Times Cited: 1

In Vitro Histone Acetylation Assay
James A. L. Brown
Current Protocols in Pharmacology (2017) Vol. 79, Iss. 1
Closed Access | Times Cited: 1

Patent Highlights February–March 2019
Hermann AM Mucke
Pharmaceutical Patent Analyst (2019) Vol. 8, Iss. 4, pp. 109-116
Closed Access | Times Cited: 1

KAT5 regulates neurodevelopmental states associated with G0-like populations in glioblastoma
Anca B. Mihalas, Sonali Arora, Samantha O’Connor, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 1

Scroll to top